Roundup of news, deals, and data from OUI for Q1 2017.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
The Oxford University spinout leads newly formed DRIVEN consortium in most ambitious autonomous vehicle trials worldwide to date.
Spinout Oxford Cancer Biomarkers announces strategic collaboration with My-BioMed Biotechnology Co. Ltd, providing precision medicine to clinicians and patients in China
SpyBiotech, an Oxford University spinout developing a molecular superglue for rapid development of vaccines targeting a range of diseases, secures £4m seed funding at launch, led by Oxford Sciences Innovation with participation from GV.
Oxford Cancer Biomarker’s ColoTox test will now be available to UK patients considering chemotherapy.
Following research showing Oxford University has produced more founders of billion-dollar startups than any other institution in Europe, Oxford University Innovation’s Gregg Bayes-Brown takes a closer look at the founders, their ties to Oxford, and the companies they’ve launched.
Oxford University Innovation’s management consultancy division to restructure as separate entity to scale up interactions and business on the world stage.
Oxford spinout Celleron Therapeutics raises funding from South Korean consortium of investors for small molecule treatments.